Publication | Closed Access

Orally active CCR5 antagonists as anti-HIV-1 agents. Part 3: Synthesis and biological activities of 1-benzazepine derivatives containing a sulfoxide moiety

MedicineActive Ccr5 Antagonists1-Benzazepine DerivativesAntiviral Drug DevelopmentAntiviral DrugHivPharmacologyAntiviral CompoundAnti-hiv-1 AgentsDrug Discovery